HCAT - Health Catalyst Inc Stock Price, Fair Value and News

7.73USD-0.06 (-0.77%)Market Closed

Market Summary

USD7.73-0.06

Market Closed

-0.77%

HCAT Stock Price

View Fullscreen

HCAT RSI Chart

HCAT Valuation

Market Cap

456.3M

Price/Earnings (Trailing)

-4.32

Price/Sales (Trailing)

1.54

Price/Free Cashflow

-25

HCAT Price/Sales (Trailing)

HCAT Profitability

Return on Equity

-29.55%

Return on Assets

-15.18%

Free Cashflow Yield

-4%

HCAT Fundamentals

HCAT Revenue

Revenue (TTM)

296.8M

Rev. Growth (Yr)

1.16%

Rev. Growth (Qtr)

-0.48%

HCAT Earnings

Earnings (TTM)

-105.5M

Earnings Growth (Yr)

37.97%

Earnings Growth (Qtr)

32.08%

Breaking Down HCAT Revenue

Last 7 days

12.5%

Last 30 days

29.1%

Last 90 days

29.5%

Trailing 12 Months

-41.4%

How does HCAT drawdown profile look like?

HCAT Financial Health

Current Ratio

4.31

Debt/Equity

0.64

Debt/Cashflow

-0.08

HCAT Investor Care

Shares Dilution (1Y)

4.93%

Diluted EPS (TTM)

-1.84

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	296.8M	0	0	0
2023	282.0M	284.6M	290.0M	295.9M
2022	254.2M	265.2M	271.8M	276.2M
2021	199.6M	215.9M	230.5M	241.9M
2020	164.8M	171.3M	179.1M	188.8M
2019	127.2M	141.0M	147.5M	154.9M
2018	0	86.2M	99.4M	112.6M
2017	0	0	0	73.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About Health Catalyst Inc

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

CEO	Mr. Daniel D. Burton
WEBSITE	healthcatalyst.com
INDUSTRY	Healthcare Plans
EMPLOYEES	1200

Health Catalyst Inc Frequently Asked Questions

What is the ticker symbol for Health Catalyst Inc? What does HCAT stand for in stocks?

HCAT is the stock ticker symbol of Health Catalyst Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Health Catalyst Inc (HCAT)?

As of Thu Jul 25 2024, market cap of Health Catalyst Inc is 459.88 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HCAT stock?

You can check HCAT's fair value in chart for subscribers.

Is Health Catalyst Inc a good stock to buy?

The fair value guage provides a quick view whether HCAT is over valued or under valued. Whether Health Catalyst Inc is cheap or expensive depends on the assumptions which impact Health Catalyst Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HCAT.

What is Health Catalyst Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jul 25 2024, HCAT's PE ratio (Price to Earnings) is -4.36 and Price to Sales (PS) ratio is 1.55. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HCAT PE ratio will change depending on the future growth rate expectations of investors.